-
Je něco špatně v tomto záznamu ?
Investigation of New Orexin 2 Receptor Modulators Using In Silico and In Vitro Methods
J. Janockova, R. Dolezal, E. Nepovimova, T. Kobrlova, M. Benkova, K. Kuca, J. Konecny, E. Mezeiova, M. Melikova, V. Hepnarova, A. Ring, O. Soukup, J. Korabecny,
Jazyk angličtina Země Švýcarsko
Typ dokumentu časopisecké články
NLK
Directory of Open Access Journals
od 1997
Free Medical Journals
od 1997
PubMed Central
od 2001
Europe PubMed Central
od 2001
ProQuest Central
od 1997-01-01
Open Access Digital Library
od 1997-01-01
Medline Complete (EBSCOhost)
od 2009-03-01
Health & Medicine (ProQuest)
od 1997-01-01
- MeSH
- antagonisté orexinových receptorů chemie farmakologie MeSH
- CHO buňky MeSH
- Cricetulus MeSH
- inhibiční koncentrace 50 MeSH
- kvantitativní vztahy mezi strukturou a aktivitou MeSH
- ligandy MeSH
- molekulární konformace MeSH
- molekulární modely * MeSH
- molekulární struktura MeSH
- orexinové receptory chemie MeSH
- orexiny chemie farmakologie MeSH
- počítačová simulace * MeSH
- racionální návrh léčiv * MeSH
- vazba proteinů MeSH
- vazebná místa MeSH
- zvířata MeSH
- Check Tag
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
The neuropeptides, orexin A and orexin B (also known as hypocretins), are produced in hypothalamic neurons and belong to ligands for orphan G protein-coupled receptors. Generally, the primary role of orexins is to act as excitatory neurotransmitters and regulate the sleep process. Lack of orexins may lead to sleep disorder narcolepsy in mice, dogs, and humans. Narcolepsy is a neurological disorder of alertness characterized by a decrease of ability to manage sleep-wake cycles, excessive daytime sleepiness, and other symptoms, such as cataplexy, vivid hallucinations, and paralysis. Thus, the discovery of orexin receptors, modulators, and their causal implication in narcolepsy is the most important advance in sleep-research. The presented work is focused on the evaluation of compounds L1−L11 selected by structure-based virtual screening for their ability to modulate orexin receptor type 2 (OX2R) in comparison with standard agonist orexin-A together with their blood-brain barrier permeability and cytotoxicity. We can conclude that the studied compounds possess an affinity towards the OX2R. However, the compounds do not have intrinsic activity and act as the antagonists of this receptor. It was shown that L4 was the most potent antagonistic ligand to orexin A and displayed an IC50 of 2.2 μM, offering some promise mainly for the treatment of insomnia.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19012158
- 003
- CZ-PrNML
- 005
- 20221026130014.0
- 007
- ta
- 008
- 190405s2018 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3390/molecules23112926 $2 doi
- 035 __
- $a (PubMed)30423961
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Janockova, Jana $u Biomedical Research Centre, University Hospital Hradec Kralove, Sokolska 581, 500 05 Hradec Kralove, Czech Republic. jana.janockova@fnhk.cz. Department of Chemistry, Faculty of Science, University of Hradec Kralove, Rokitanskeho 62, 500 03 Hradec Kralove, Czech Republic. jana.janockova@fnhk.cz.
- 245 10
- $a Investigation of New Orexin 2 Receptor Modulators Using In Silico and In Vitro Methods / $c J. Janockova, R. Dolezal, E. Nepovimova, T. Kobrlova, M. Benkova, K. Kuca, J. Konecny, E. Mezeiova, M. Melikova, V. Hepnarova, A. Ring, O. Soukup, J. Korabecny,
- 520 9_
- $a The neuropeptides, orexin A and orexin B (also known as hypocretins), are produced in hypothalamic neurons and belong to ligands for orphan G protein-coupled receptors. Generally, the primary role of orexins is to act as excitatory neurotransmitters and regulate the sleep process. Lack of orexins may lead to sleep disorder narcolepsy in mice, dogs, and humans. Narcolepsy is a neurological disorder of alertness characterized by a decrease of ability to manage sleep-wake cycles, excessive daytime sleepiness, and other symptoms, such as cataplexy, vivid hallucinations, and paralysis. Thus, the discovery of orexin receptors, modulators, and their causal implication in narcolepsy is the most important advance in sleep-research. The presented work is focused on the evaluation of compounds L1−L11 selected by structure-based virtual screening for their ability to modulate orexin receptor type 2 (OX2R) in comparison with standard agonist orexin-A together with their blood-brain barrier permeability and cytotoxicity. We can conclude that the studied compounds possess an affinity towards the OX2R. However, the compounds do not have intrinsic activity and act as the antagonists of this receptor. It was shown that L4 was the most potent antagonistic ligand to orexin A and displayed an IC50 of 2.2 μM, offering some promise mainly for the treatment of insomnia.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a vazebná místa $7 D001665
- 650 _2
- $a CHO buňky $7 D016466
- 650 12
- $a počítačová simulace $7 D003198
- 650 _2
- $a Cricetulus $7 D003412
- 650 12
- $a racionální návrh léčiv $7 D015195
- 650 _2
- $a inhibiční koncentrace 50 $7 D020128
- 650 _2
- $a ligandy $7 D008024
- 650 12
- $a molekulární modely $7 D008958
- 650 _2
- $a molekulární konformace $7 D008968
- 650 _2
- $a molekulární struktura $7 D015394
- 650 _2
- $a antagonisté orexinových receptorů $x chemie $x farmakologie $7 D000068796
- 650 _2
- $a orexinové receptory $x chemie $7 D064446
- 650 _2
- $a orexiny $x chemie $x farmakologie $7 D000068797
- 650 _2
- $a vazba proteinů $7 D011485
- 650 _2
- $a kvantitativní vztahy mezi strukturou a aktivitou $7 D021281
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Dolezal, Rafael $u Biomedical Research Centre, University Hospital Hradec Kralove, Sokolska 581, 500 05 Hradec Kralove, Czech Republic. Rafael.dolezal@fnhk.cz. Department of Chemistry, Faculty of Science, University of Hradec Kralove, Rokitanskeho 62, 500 03 Hradec Kralove, Czech Republic. Rafael.dolezal@fnhk.cz. Center for Basic and Applied Research, University of Hradec Kralove, Rokitanskeho 62, 500 03 Hradec Kralove, Czech Republic. Rafael.dolezal@fnhk.cz.
- 700 1_
- $a Nepovimova, Eugenie $u Department of Chemistry, Faculty of Science, University of Hradec Kralove, Rokitanskeho 62, 500 03 Hradec Kralove, Czech Republic. eugenie.nepovimova@uhk.cz.
- 700 1_
- $a Kobrlová, Tereza, $u Biomedical Research Centre, University Hospital Hradec Kralove, Sokolska 581, 500 05 Hradec Kralove, Czech Republic. tereza.kobrlova@fnhk.cz. Department of Toxicology and Military Pharmacy, Faculty of Military Health Sciences, University of Defence, Trebesska 1575, 500 05 Hradec Kralove, Czech Republic. tereza.kobrlova@fnhk.cz. $d 1991- $7 xx0277928
- 700 1_
- $a Benkova, Marketa $u Biomedical Research Centre, University Hospital Hradec Kralove, Sokolska 581, 500 05 Hradec Kralove, Czech Republic. marketa.benkova@fnhk.cz.
- 700 1_
- $a Kuca, Kamil $u Biomedical Research Centre, University Hospital Hradec Kralove, Sokolska 581, 500 05 Hradec Kralove, Czech Republic. kamil.kuca@fnhk.cz. Department of Chemistry, Faculty of Science, University of Hradec Kralove, Rokitanskeho 62, 500 03 Hradec Kralove, Czech Republic. kamil.kuca@fnhk.cz.
- 700 1_
- $a Konecny, Jan $u Biomedical Research Centre, University Hospital Hradec Kralove, Sokolska 581, 500 05 Hradec Kralove, Czech Republic. jan.konecny@fnhk.cz. Department of Chemistry, Faculty of Science, University of Hradec Kralove, Rokitanskeho 62, 500 03 Hradec Kralove, Czech Republic. jan.konecny@fnhk.cz.
- 700 1_
- $a Mezeiová, Eva $u Biomedical Research Centre, University Hospital Hradec Kralove, Sokolska 581, 500 05 Hradec Kralove, Czech Republic. eva.mezeiova@fnhk.cz. $7 xx0277560
- 700 1_
- $a Melikova, Michaela $u Department of Chemistry, Faculty of Science, University of Hradec Kralove, Rokitanskeho 62, 500 03 Hradec Kralove, Czech Republic. michaela.melikova@upol.cz.
- 700 1_
- $a Hepnarova, Vendula $u Biomedical Research Centre, University Hospital Hradec Kralove, Sokolska 581, 500 05 Hradec Kralove, Czech Republic. vendula.hepnarova@unob.cz. Department of Toxicology and Military Pharmacy, Faculty of Military Health Sciences, University of Defence, Trebesska 1575, 500 05 Hradec Kralove, Czech Republic. vendula.hepnarova@unob.cz.
- 700 1_
- $a Ring, Avi $u Norwegian Defence Research Establishment, Gunnar Randersvei 42, 2007 Kjeller, Norway. avi.ring@ffi.no.
- 700 1_
- $a Soukup, Ondrej $u Biomedical Research Centre, University Hospital Hradec Kralove, Sokolska 581, 500 05 Hradec Kralove, Czech Republic. ondrej.soukup@fnhk.cz. Department of Toxicology and Military Pharmacy, Faculty of Military Health Sciences, University of Defence, Trebesska 1575, 500 05 Hradec Kralove, Czech Republic. ondrej.soukup@fnhk.cz.
- 700 1_
- $a Korabecny, Jan $u Biomedical Research Centre, University Hospital Hradec Kralove, Sokolska 581, 500 05 Hradec Kralove, Czech Republic. jan.korabecny@fnhk.cz. Department of Toxicology and Military Pharmacy, Faculty of Military Health Sciences, University of Defence, Trebesska 1575, 500 05 Hradec Kralove, Czech Republic. jan.korabecny@fnhk.cz.
- 773 0_
- $w MED00180394 $t Molecules $x 1420-3049 $g Roč. 23, č. 11 (2018)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/30423961 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20190405 $b ABA008
- 991 __
- $a 20221026130011 $b ABA008
- 999 __
- $a ok $b bmc $g 1391468 $s 1050463
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2018 $b 23 $c 11 $e 20181109 $i 1420-3049 $m Molecules $n Molecules $x MED00180394
- LZP __
- $a Pubmed-20190405